Ridgecrest Wealth Partners LLC Sells 725 Shares of The Clorox Company (NYSE:CLX)

Ridgecrest Wealth Partners LLC cut its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 24.8% during the 4th quarter, Holdings Channel reports. The firm owned 2,204 shares of the company’s stock after selling 725 shares during the period. Ridgecrest Wealth Partners LLC’s holdings in Clorox were worth $358,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CLX. Insight Folios Inc increased its stake in Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after acquiring an additional 63 shares during the period. HCR Wealth Advisors grew its holdings in shares of Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares in the last quarter. SPC Financial Inc. increased its position in shares of Clorox by 2.2% in the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after purchasing an additional 75 shares during the period. Massmutual Trust Co. FSB ADV raised its stake in Clorox by 17.2% in the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after purchasing an additional 75 shares in the last quarter. Finally, Empower Advisory Group LLC lifted its position in Clorox by 4.5% during the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after purchasing an additional 78 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CLX has been the subject of several analyst reports. DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Barclays decreased their price target on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and upped their price objective for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $156.54.

Read Our Latest Stock Analysis on CLX

Clorox Stock Performance

Shares of CLX stock opened at $159.12 on Monday. The firm has a market capitalization of $19.70 billion, a price-to-earnings ratio of 55.44, a PEG ratio of 2.92 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The business’s 50-day moving average price is $163.66 and its 200-day moving average price is $157.66. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the company earned $0.49 EPS. The firm’s revenue was up 27.0% compared to the same quarter last year. Equities research analysts forecast that The Clorox Company will post 6.87 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.07%. Clorox’s payout ratio is 170.04%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.